Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05137782 · ClinicalTrials.gov registry record · NA
The Science of the Art of Palliative Care
A NA study of Lung Cancer and Advanced Cancer, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT05137782: Completed NA study of Lung Cancer and Advanced Cancer, sponsored by Dartmouth-Hitchcock Medical Center.
NCT05137782 is a NA study of Lung Cancer and Advanced Cancer that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 7 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05137782, a NA study of Lung Cancer and Advanced Cancer, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
This feasibility pilot study is designed to learn whether patients and their care partners (e.g., family members) are willing and able to complete two study visits at Dartmouth College while receiving cancer care at Dartmouth-Hitchcock Medical Center.
Primary Outcome
Establish acceptable operating procedures and data collection instruments which can be replicated for future projects.
Conditions Studied
Interventions
- OTHER Specialty Palliative Care
Study Locations (1)
New Hampshire
- Dartmouth-Hitchcock Medical Center - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-01-03 |
| Est. Completion | 2023-11-30 |
| Phase | NA |
What the finished NCT05137782 record still lists
NCT05137782 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Specialty Palliative Care is the first listed.
NCT05137782 reports a single indexed study location in New Hampshire.
Frequently Asked Questions
What is clinical trial NCT05137782 about?
NCT05137782 is a clinical study titled "The Science of the Art of Palliative Care". This feasibility pilot study is designed to learn whether patients and their care partners (e.g., family members) are willing and able to complete two study visits at Dartmouth College while receiving cancer care at Dartmouth-Hitchcock Medical Center.
What is the current status of trial NCT05137782?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2023-01-03. Estimated completion is 2023-11-30.
What conditions does trial NCT05137782 study?
This clinical trial studies the following conditions: Lung Cancer, Advanced Cancer, Gastrointestinal Cancer.
What interventions are being tested in trial NCT05137782?
The interventions under investigation include: Specialty Palliative Care (OTHER).
Who is sponsoring clinical trial NCT05137782?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05137782 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05137782's enrollment target sits among peer trials
7 402nd of 409 higher than 7 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI